annual D&A:
$6.08M-$419.00K(-6.45%)Summary
- As of today (May 29, 2025), BBIO annual depreciation & amortization is $6.08 million, with the most recent change of -$419.00 thousand (-6.45%) on December 31, 2024.
- During the last 3 years, BBIO annual D&A has risen by +$232.00 thousand (+3.97%).
- BBIO annual D&A is now -10.28% below its all-time high of $6.77 million, reached on December 31, 2022.
Performance
BBIO Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.28M-$83.00K(-6.07%)Summary
- As of today (May 29, 2025), BBIO quarterly depreciation & amortization is $1.28 million, with the most recent change of -$83.00 thousand (-6.07%) on March 31, 2025.
- Over the past year, BBIO quarterly D&A has dropped by -$312.00 thousand (-19.55%).
- BBIO quarterly D&A is now -63.17% below its all-time high of $3.49 million, reached on June 30, 2021.
Performance
BBIO quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$5.76M-$312.00K(-5.14%)Summary
- As of today (May 29, 2025), BBIO TTM depreciation & amortization is $5.76 million, with the most recent change of -$312.00 thousand (-5.14%) on March 31, 2025.
- Over the past year, BBIO TTM D&A has dropped by -$694.00 thousand (-10.75%).
- BBIO TTM D&A is now -19.52% below its all-time high of $7.16 million, reached on March 31, 2022.
Performance
BBIO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BBIO Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.5% | -19.6% | -10.8% |
| 3 y3 years | +4.0% | -31.9% | -19.5% |
| 5 y5 years | +607.2% | +137.3% | +965.3% |
BBIO Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.3% | +4.0% | -31.9% | at low | -19.5% | +9.6% |
| 5 y | 5-year | -10.3% | +607.2% | -63.2% | +226.5% | -19.5% | +965.3% |
| alltime | all time | -10.3% | >+9999.0% | -63.2% | +226.5% | -19.5% | >+9999.0% |
BBIO Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.28M(-6.1%) | $5.76M(-5.1%) |
| Dec 2024 | $6.08M(-6.5%) | $1.37M(-11.1%) | $6.08M(-3.5%) |
| Sep 2024 | - | $1.54M(-2.3%) | $6.29M(-1.6%) |
| Jun 2024 | - | $1.57M(-1.4%) | $6.39M(-1.0%) |
| Mar 2024 | - | $1.60M(+0.7%) | $6.46M(-0.6%) |
| Dec 2023 | $6.49M(-4.1%) | $1.58M(-3.3%) | $6.49M(-1.1%) |
| Sep 2023 | - | $1.64M(+0.1%) | $6.57M(-0.1%) |
| Jun 2023 | - | $1.64M(+0.2%) | $6.58M(+0.8%) |
| Mar 2023 | - | $1.63M(-1.6%) | $6.52M(-3.7%) |
| Dec 2022 | $6.77M(+15.9%) | $1.66M(+0.9%) | $6.77M(+2.0%) |
| Sep 2022 | - | $1.65M(+4.0%) | $6.64M(+26.3%) |
| Jun 2022 | - | $1.58M(-16.0%) | $5.26M(-26.6%) |
| Mar 2022 | - | $1.88M(+23.5%) | $7.16M(+22.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $5.84M(+301.3%) | $1.53M(+475.8%) | $5.84M(+23.0%) |
| Sep 2021 | - | $265.00K(-92.4%) | $4.75M(+36.9%) |
| Jun 2021 | - | $3.49M(+515.9%) | $3.47M(+134.4%) |
| Mar 2021 | - | $566.00K(+30.1%) | $1.48M(+1.7%) |
| Dec 2020 | $1.46M(+69.5%) | $435.00K(-142.9%) | $1.46M(+42.6%) |
| Sep 2020 | - | -$1.01M(-167.9%) | $1.02M(-49.9%) |
| Jun 2020 | - | $1.50M(+176.3%) | $2.04M(+276.3%) |
| Mar 2020 | - | $541.00K(-473.1%) | $541.00K(>+9900.0%) |
| Dec 2019 | $859.00K(>+9900.0%) | - | - |
| Dec 2018 | $0.00 | -$145.00K(-288.3%) | $0.00(-100.0%) |
| Sep 2018 | - | $77.00K(+83.3%) | $145.00K(+113.2%) |
| Jun 2018 | - | $42.00K(+61.5%) | $68.00K(+161.5%) |
| Mar 2018 | - | $26.00K | $26.00K |
FAQ
- What is BridgeBio Pharma annual depreciation & amortization?
- What is the all time high annual D&A for BridgeBio Pharma?
- What is BridgeBio Pharma annual D&A year-on-year change?
- What is BridgeBio Pharma quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly D&A year-on-year change?
- What is BridgeBio Pharma TTM depreciation & amortization?
- What is the all time high TTM D&A for BridgeBio Pharma?
- What is BridgeBio Pharma TTM D&A year-on-year change?
What is BridgeBio Pharma annual depreciation & amortization?
The current annual D&A of BBIO is $6.08M
What is the all time high annual D&A for BridgeBio Pharma?
BridgeBio Pharma all-time high annual depreciation & amortization is $6.77M
What is BridgeBio Pharma annual D&A year-on-year change?
Over the past year, BBIO annual depreciation & amortization has changed by -$419.00K (-6.45%)
What is BridgeBio Pharma quarterly depreciation & amortization?
The current quarterly D&A of BBIO is $1.28M
What is the all time high quarterly D&A for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly depreciation & amortization is $3.49M
What is BridgeBio Pharma quarterly D&A year-on-year change?
Over the past year, BBIO quarterly depreciation & amortization has changed by -$312.00K (-19.55%)
What is BridgeBio Pharma TTM depreciation & amortization?
The current TTM D&A of BBIO is $5.76M
What is the all time high TTM D&A for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM depreciation & amortization is $7.16M
What is BridgeBio Pharma TTM D&A year-on-year change?
Over the past year, BBIO TTM depreciation & amortization has changed by -$694.00K (-10.75%)